Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

· להראות הערות
01:59:30
Podcasts
RSS
Link

אודות פרק זה

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

  • Introduction (0:00)
  • Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
  • Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
  • CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
  • Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
  • Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

רפואה
השכלה
בריאות וכושר
רפואה
מדע
אנגלית
ארצות הברית
השתמש ב-APIכדי להביא פרק זה ב-JSON

בפרק זה

ערוך תגיות אלה

הראה הערות 🔗

00:00:00Introduction
00:07:05Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles
00:26:21Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel
00:43:12Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar
01:08:33CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles
01:24:44Other Approved and Emerging Novel Therapies for FL — Dr Patel
01:41:34Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar

תעתיק 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

חיפוש פרקים ישנים

חפש פרקים קודמים של Oncology Today with Dr Neil Love.
הטמע סרגל חיפוש זה לאתר שלך

פרקים אחרים בפודקאסט הזה

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III H‮…
00:24:03
שתף
שמור
Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics: Case: A woman in her mid 50s with BRCA1-mutated recurrent ovarian cancer receives mirvetuximab soravtansine — Ursula M‮…
00:12:17
שתף
שמור
Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and‮…
01:58:22
שתף
שמור
Chronic Lymphocytic Leukemia — Microlearning Activity 1

Chronic Lymphocytic Leukemia — Microlearning Activity 1

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in treatment-naïve chronic lymphocytic leukemia (CLL) (0:00) Feasibility of discontinuation of Bruton tyrosine kinase (BTK) inhibitor th‮…
00:24:32
שתף
שמור
Chronic Lymphocytic Leukemia — Microlearning Activity 2

Chronic Lymphocytic Leukemia — Microlearning Activity 2

Featuring perspectives from Dr Catherine C Coombs, including the following topics: Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax and rituximab for previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) (0:00) Role o‮…
00:27:51
שתף
שמור
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Dr. Neil Love, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
PROMOTED
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Listen411.com: Lightning-fast Podcast Transcription and Summarization. Transcribe 1-hour audio in under 1 minute. Pay-as-you-go.
Audio to Text

המלצות
השתמש/י בממשק ה-API כדי להביא פרק זה